MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-29-2026
Pro-Dex EPS Ratio 2011-2026 | PDEX
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Pro-Dex
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.73 | 0.61 | 1.98 | 0.8 | 0.3 | 0.46 | 0.99 | 0.38 | 1.26 | 0.2 | -0.09 | -0.14 | -0.54 | -0.27 | 0.81 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.73 | -0.54 | 0.632 |
Quarterly EPS Ratio Pro-Dex
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.67 | - | 1 | 0.63 | 0.76 | - | 0.19 | 0.14 | -0.17 | - | 0.46 | 0.77 | 0.33 | 0.54 | 0.13 | 0.25 | 0.29 | 0.54 | 0.56 | 0.45 | 0.3 | 0.09 | 0.33 | 0.32 | 0.28 | 0.32 | 0.28 | 0.28 | 0.31 | 0.28 | 0.31 | 0.08 | 0.15 | 0.08 | 0.15 | 0.79 | 0.07 | 0.79 | 0.09 | 0.09 | -0.1 | 0.09 | -0.02 | -0.05 | -0.04 | -0.05 | -0.04 | -0.1 | 0.06 | -0.04 | 0.06 | -0.11 | -0.01 | -0.11 | -0.01 | -0.09 | 0.14 | -0.09 | 0.14 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1 | -0.17 | 0.224 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical instruments industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
11 | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
-1.39 | $ 122.35 | - | $ 3.92 B | USA |
 |
Repro Med Systems
KRMD
|
-0.06 | $ 3.96 | - | $ 183 M | USA |
 |
Milestone Scientific
MLSS
|
-0.07 | $ 0.32 | 1.28 % | $ 26.3 M | USA |
 |
Alcon
ALC
|
0.77 | $ 75.8 | - | $ 40.4 B |  Schweiz |
 |
STERIS plc
STE
|
6.24 | $ 221.8 | - | $ 21.9 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-4.91 | $ 10.99 | - | $ 26.7 M | USA |
 |
Teleflex Incorporated
TFX
|
-16.1 | $ 136.56 | - | $ 6.09 B | USA |
 |
The Cooper Companies
COO
|
1.88 | $ 64.42 | - | $ 12.8 B | USA |
 |
Utah Medical Products
UTMD
|
3.48 | $ 67.17 | - | $ 218 M | USA |
 |
Haemonetics Corporation
HAE
|
3.33 | $ 59.93 | - | $ 3.02 B | USA |
 |
electroCore
ECOR
|
-1.65 | $ 6.18 | -0.08 % | $ 52.4 K | USA |
 |
ICU Medical
ICUI
|
0.03 | $ 124.82 | 0.22 % | $ 3.08 B | USA |
 |
Envista Holdings Corporation
NVST
|
0.28 | $ 26.8 | - | $ 4.5 B | USA |
 |
Microbot Medical
MBOT
|
-0.29 | $ 2.2 | - | $ 101 M |  Israel |
 |
West Pharmaceutical Services
WST
|
6.83 | $ 306.16 | - | $ 22.1 B | USA |
 |
Isoray
ISR
|
-1.4 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
8 | $ 482.22 | - | $ 172 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-3 | $ 11.91 | - | $ 2.37 B | USA |
 |
Glaukos Corporation
GKOS
|
-2.78 | $ 121.48 | - | $ 5.88 B | USA |
 |
Masimo Corporation
MASI
|
-5.72 | $ 178.63 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
0.07 | $ 10.34 | - | $ 214 M | USA |
 |
Merit Medical Systems
MMSI
|
2.17 | $ 68.58 | - | $ 4.06 B | USA |
 |
Pulse Biosciences
PLSE
|
-1.08 | $ 23.02 | - | $ 1.55 B | USA |
 |
Retractable Technologies
RVP
|
-0.43 | $ 0.65 | - | $ 19.5 M | USA |
 |
LeMaitre Vascular
LMAT
|
2.55 | $ 113.45 | - | $ 2.57 B | USA |
 |
Predictive Oncology
POAI
|
-13.4 | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
-1.62 | $ 25.67 | - | $ 1.27 B | USA |
 |
BioLife Solutions
BLFS
|
-0.44 | $ 21.38 | - | $ 985 M | USA |
 |
Stereotaxis
STXS
|
-0.25 | $ 1.93 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
-1.87 | $ 18.16 | - | $ 9.32 B | USA |
 |
ResMed
RMD
|
5.34 | $ 219.85 | - | $ 32.1 B | USA |
 |
AtriCure
ATRC
|
-0.24 | $ 29.28 | - | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
-1.28 | $ 6.86 | 1.18 % | $ 305 M | USA |
 |
NeuroMetrix
NURO
|
-3.96 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-0.83 | $ 11.1 | - | $ 453 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.83 | $ 152.14 | - | $ 43.8 B | USA |
 |
Nephros
NEPH
|
-0.15 | $ 2.87 | 1.06 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
-0.94 | $ 3.0 | -1.64 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
0.64 | $ 117.6 | - | $ 6.55 M | USA |